| 📊 Alain’s Holdings — August 19, 2026 | ||||
|---|---|---|---|---|
| Symbol | Name | Price | Change | Change % |
| VOO | Vanguard S&P 500 ETF | 706.91 | +1.51 | +0.21% |
| QQQ | Invesco QQQ Trust | 716.08 | -1.43 | -0.20% |
| XIU.TO | iShares S&P/TSX 60 ETF | 54.12 | -0.16 | -0.29% |
Wall Street finally broke its three-day losing streak Wednesday as a sharp decline in Treasury yields gave stocks some breathing room.
The catalyst came from an unexpected place: the U.S. Treasury Department.
Treasury announced plans to substantially increase buybacks of long-dated government debt, helping push bond yields lower after they had recently reached levels not seen in nearly two decades.
Market Performance
- 📈 Dow Jones Industrial Average: +0.2%
- 📈 S&P 500: +0.2%
- 📈 Nasdaq Composite: +0.2%
The gains were modest, but after three consecutive declines, investors welcomed the change in direction.
Treasury Steps In — Yields Fall
The day’s biggest market-moving development came from the bond market.
The Treasury Department announced that it plans to increase buybacks of long-dated government securities “by at least double,” covering maturities from 10 to 30 years.
Bond prices rallied following the announcement, pushing yields sharply lower.
- 10-year Treasury yield: 4.65%, down about 5 basis points
- 30-year Treasury yield: 5.19%, down about 9 basis points
That’s particularly notable because the 30-year yield had reached its highest level since 2007 earlier this week.
Why did stocks care?
Higher Treasury yields increase borrowing costs and give investors a more attractive alternative to stocks.
The reverse is also true.
When yields fall, equity valuations—particularly expensive technology stocks—get some relief.
Moderna Explodes 176%
The day’s most spectacular move belonged to Moderna.
Shares surged an extraordinary 176% after the biotechnology company reported positive late-stage trial results for an experimental melanoma vaccine developed with Merck.
The enormous move illustrates both the opportunity and risk inherent in biotechnology investing.
A successful clinical trial can dramatically change the expected value of a company’s drug pipeline almost overnight.
Unlike many of today’s AI-driven stock moves, Moderna’s rally came from an entirely different source of innovation:
medicine.
Trump Pauses 50% Canadian Tariffs
Investors also received encouraging news on trade.
President Trump announced Tuesday night that planned 50% tariffs on Canadian goods would be paused for three days, saying the United States and Canada had reached a deal subject to final documentation.
The announcement followed last-minute negotiations between U.S. officials and the government of Canadian Prime Minister Mark Carney.
The immediate economic effect of the proposed tariffs may have been limited, but the negotiations have broader significance.
The U.S., Canada and Mexico are approaching another important round of discussions surrounding USMCA, meaning Wednesday’s development could offer clues about how contentious those negotiations become.
The Fed Isn’t Finished With Inflation
Falling Treasury yields helped stocks Wednesday, but the Federal Reserve delivered a reminder that interest-rate risk hasn’t disappeared.
Minutes from the Fed’s most recent meeting showed that several policymakers favored raising interest rates.
Officials indicated additional tightening could become necessary if inflation doesn’t continue moving lower.
That’s important because recent economic data has been sending conflicting signals.
Inflation has cooled.
But it remains above the Fed’s 2% target.
Employment has weakened.
Consumer spending has softened.
But oil remains near $90 per barrel.
The Federal Reserve therefore faces an increasingly difficult balancing act.
Raise rates too aggressively and policymakers risk further weakening the economy.
Remain too patient and inflation could accelerate again.
The Bottom Line
Wednesday’s rally wasn’t spectacular.
But after three consecutive losing sessions, it was important.
The market’s biggest recent obstacle has been rising interest rates.
Today, that pressure eased.
The 30-year Treasury yield dropped from a 19-year high, stocks moved higher, and investors received some relief on U.S.-Canada trade tensions.
But today’s Fed minutes make one thing clear:
The interest-rate debate isn’t over.
Inflation will ultimately determine whether Wednesday’s decline in yields becomes the beginning of a lasting trend—or merely a temporary reprieve.
For now, Wall Street will take the win.
Other Stock Market blog posts
Leave a Reply